[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Andres_DelRisco Andres Del Risco
Andres Del Risco posts on X about $amat, $lrcx, $gsk, lineup the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXX -XX%
- X Month XXXXXX +3,058%
- X Months XXXXXX +62,592%
- X Year XXXXXX +1,482%
Mentions: X #
- X Week XX -XX%
- X Month XX +300%
- X Months XX +4,750%
- X Year XX +607%
Followers: XXX #
- X Week XXX -XXXX%
- X Month XXX +27%
- X Months XXX +30%
- X Year XXX -XXXX%
CreatorRank: undefined #
Social Influence #
Social category influence stocks XXXXX% finance XXXX%
Social topic influence $amat 4.35%, $lrcx 4.35%, $gsk 4.35%, lineup 4.35%, dividend yield 4.35%, blockbuster 4.35%, drugs 4.35%, $oklo 4.35%, $pep 4.35%, $229share XXXX%
Top accounts mentioned or mentioned by @business @bellawallerstei @stocksavvyshay @futurumequities @danielpriestley
Top assets mentioned Applied Materials, Inc. (AMAT) Lam Research Corporation (LRCX) GSK plc (GSK) Oklo Inc. (OKLO) PepsiCo, Inc. (PEP)
Top Social Posts #
Top posts by engagements in the last XX hours
"Applied Materials (AMAT) and Lam Research (LRCX): Semiconductor equipment makers reliant on AI chip production ramps. Analyst: XXX Fair value: XXX P/E: 26x"
X Link @Andres_DelRisco 2025-10-04T10:40Z XXX followers, XX engagements
"$GSK GSKs blockbuster lineup portfolio is a global powerhouse that is transforming lives and driving innovation GSK is a compelling portfolio addition due to its undervalued stock (P/E 8.9x) XXX% dividend yield X% EPS growth and strong pipeline in vaccines (Shingrix Arexvy) and HIV with 31B+ turnover and innovative oncology drugs. #HealthInnovation #GSK #Pharma GSK TOP SELLING PRODUCTS: Shingrix: A vaccine for shingles it is consistently one of GSK's top-selling products. Arexvy: A vaccine for Alzheimer's disease that has driven growth in GSK's Vaccines segment. Trelegy: A treatment for"
X Link @Andres_DelRisco 2025-10-05T19:30Z XXX followers, XX engagements
"@StockSavvyShay @FuturumEquities Well thank you OKLO FUJI and CAMECO. Anything nuclear energy and uranium related has a great future to power AI technology and AI digital tools"
X Link @Andres_DelRisco 2025-10-04T20:43Z XXX followers, 1040 engagements
"PepsiCo pops off Q3 earnings fizz at $2.29/share topping $XXXX estimates. Revenue sparkles at $23.94B beating $23.86B forecasts with a XXX% YOY rise. Sipping success one can at a time. Lets see how the market reacts $pep #pep #pepsico #pepsi #earnings"
X Link @Andres_DelRisco 2025-10-09T10:23Z XXX followers, XXX engagements